Embecta Management

Management criteria checks 3/4

Embecta's CEO is Dev Kurdikar, appointed in Apr 2022, has a tenure of 3.17 years. total yearly compensation is $8.59M, comprised of 10.4% salary and 89.6% bonuses, including company stock and options. directly owns 0.85% of the company’s shares, worth $5.02M. The average tenure of the management team and the board of directors is 3.2 years and 3.2 years respectively.

Key information

Dev Kurdikar

Chief executive officer

US$8.6m

Total compensation

CEO salary percentage10.41%
CEO tenure3.2yrs
CEO ownership0.9%
Management average tenure3.2yrs
Board average tenure3.2yrs

Recent management updates

Recent updates

Embecta (NASDAQ:EMBC) Has Announced A Dividend Of $0.15

May 22
Embecta (NASDAQ:EMBC) Has Announced A Dividend Of $0.15

What Is Embecta Corp.'s (NASDAQ:EMBC) Share Price Doing?

May 09
What Is Embecta Corp.'s (NASDAQ:EMBC) Share Price Doing?

Embecta Corp.'s (NASDAQ:EMBC) Intrinsic Value Is Potentially 87% Above Its Share Price

Mar 06
Embecta Corp.'s (NASDAQ:EMBC) Intrinsic Value Is Potentially 87% Above Its Share Price

Embecta: Weak Outlook But Mouth-Watering Valuation Skew Risk-Reward In Favour

Feb 28

New Initiatives Expected To Make Embecta More Profitable

Dec 04

Embecta (NASDAQ:EMBC) Is Due To Pay A Dividend Of $0.15

Nov 29
Embecta (NASDAQ:EMBC) Is Due To Pay A Dividend Of $0.15

At US$16.33, Is It Time To Put Embecta Corp. (NASDAQ:EMBC) On Your Watch List?

Nov 07
At US$16.33, Is It Time To Put Embecta Corp. (NASDAQ:EMBC) On Your Watch List?

It's A Story Of Risk Vs Reward With Embecta Corp. (NASDAQ:EMBC)

Sep 24
It's A Story Of Risk Vs Reward With Embecta Corp. (NASDAQ:EMBC)
author-image

Expanding Global Leadership In Insulin Devices Fuels Revenue Growth And Operational Efficiencies

Strengthening the base business in insulin injection devices suggests potential for stable, growing revenues as the global demographic needing these devices increases.

Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15

Aug 16
Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15

Embecta Corp. Just Beat EPS By 79%: Here's What Analysts Think Will Happen Next

Aug 14
Embecta Corp. Just Beat EPS By 79%: Here's What Analysts Think Will Happen Next

When Should You Buy Embecta Corp. (NASDAQ:EMBC)?

Jul 13
When Should You Buy Embecta Corp. (NASDAQ:EMBC)?

Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

May 12
Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15

Feb 21
Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15

Embecta Corp.'s (NASDAQ:EMBC) Prospects Need A Boost To Lift Shares

Jul 16
Embecta Corp.'s (NASDAQ:EMBC) Prospects Need A Boost To Lift Shares

Embecta Corp. (NASDAQ:EMBC) Shares Could Be 37% Below Their Intrinsic Value Estimate

Mar 30
Embecta Corp. (NASDAQ:EMBC) Shares Could Be 37% Below Their Intrinsic Value Estimate

Embecta Corp. Just Recorded A 22% EPS Beat: Here's What Analysts Are Forecasting Next

Feb 17
Embecta Corp. Just Recorded A 22% EPS Beat: Here's What Analysts Are Forecasting Next

CEO Compensation Analysis

How has Dev Kurdikar's remuneration changed compared to Embecta's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

US$53m

Dec 31 2024n/an/a

US$58m

Sep 30 2024US$9mUS$894k

US$78m

Jun 30 2024n/an/a

US$70m

Mar 31 2024n/an/a

US$70m

Dec 31 2023n/an/a

US$55m

Sep 30 2023US$7mUS$863k

US$70m

Jun 30 2023n/an/a

US$47m

Mar 31 2023n/an/a

US$94m

Dec 31 2022n/an/a

US$160m

Sep 30 2022US$11mUS$791k

US$224m

Jun 30 2022n/an/a

US$338m

Mar 31 2022n/an/a

US$380m

Dec 31 2021n/an/a

US$408m

Sep 30 2021US$3mUS$447k

US$415m

Compensation vs Market: Dev's total compensation ($USD8.59M) is above average for companies of similar size in the US market ($USD2.69M).

Compensation vs Earnings: Dev's compensation has been consistent with company performance over the past year.


CEO

Dev Kurdikar (56 yo)

3.2yrs
Tenure
US$8,587,473
Compensation

Mr. Devdatt Kurdikar, also known as Dev, Ph.D. is an Independent Director at Zimmer Biomet Holdings, Inc since June 20, 2024. He serves as Chief Executive Officer and Director at Embecta Corp. since April...


Leadership Team

NamePositionTenureCompensationOwnership
Devdatt Kurdikar
President3.2yrsUS$8.59m0.85%
$ 5.0m
Jacob Elguicze
Senior VP & CFO3.2yrsUS$3.12m0.29%
$ 1.7m
Jeffrey Mann
Senior VPno dataUS$2.59m0.24%
$ 1.4m
Jean Casner
Senior VP & Chief Human Resources Officerno dataUS$1.34m0.0049%
$ 28.8k
Shaun Curtis
Senior Vice President of Global Manufacturing & Supply Chainno dataUS$1.68m0.10%
$ 593.0k
Anthony Roth
VP, Chief Accounting Officer & Corporate Controllerless than a yearno data0.027%
$ 158.2k
Colleen Riley
Senior VP & Chief Technology Officerno datano datano data
Pravesh Khandelwal
VP & Head of Investor Relationsno datano datano data
Ginny Blocki
Senior Vice President of Global Marketing & Product Managementno datano datano data
Tom Blount
Senior VP & President of North Americano datano datano data
Slobodan Radumilo
Senior VP & President of Internationalno datano datano data
3.2yrs
Average Tenure
54yo
Average Age

Experienced Management: EMBC's management team is considered experienced (3.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Devdatt Kurdikar
President3.2yrsUS$8.59m0.85%
$ 5.0m
Claire Pomeroy
Independent Director3.2yrsUS$293.00k0.047%
$ 275.6k
Christopher Reidy
Director3.2yrsUS$288.00k0.054%
$ 315.7k
Robert Hombach
Independent Director3.3yrsUS$292.00k0.044%
$ 260.1k
David Melcher
Independent Non-Executive Chairman3.2yrsUS$392.01k0.15%
$ 870.3k
Milton Morris
Independent Director3.2yrsUS$277.00k0.038%
$ 223.9k
David Albritton
Independent Director3.2yrsUS$272.00k0.044%
$ 260.1k
Karen Prange
Independent Director3.2yrsUS$288.00k0.044%
$ 260.1k
Carrie Anderson
Independent Director3.2yrsUS$277.00k0.044%
$ 260.1k
3.2yrs
Average Tenure
59yo
Average Age

Experienced Board: EMBC's board of directors are considered experienced (3.2 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/17 18:27
End of Day Share Price 2025/06/17 00:00
Earnings2025/03/31
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Embecta Corp. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Travis SteedBofA Global Research
Travis SteedBofA Global Research
Michael GormanBTIG